Results for tag: "G Protein Coupled Receptor"

The G Protein Coupled Receptor (GPCR) market is a subset of the Central Nervous System (CNS) drug market. GPCRs are a class of proteins that are found in the cell membrane and are involved in the transmission of signals from outside the cell to the inside. GPCRs are important targets for drug discovery and development, as they are involved in a wide range of physiological processes, including pain, inflammation, and neurological disorders. GPCRs are also involved in the regulation of hormones, neurotransmitters, and other signaling molecules. GPCR-targeted drugs are used to treat a variety of CNS disorders, including depression, anxiety, schizophrenia, and Alzheimer's disease. These drugs are also used to treat other conditions, such as obesity, hypertension, and diabetes. GPCR-targeted drugs are typically small molecules, which are easier to develop and manufacture than biologics. The GPCR market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the GPCR market include Pfizer, Merck, Novartis, GlaxoSmithKline, and AstraZeneca. Show Less Read more